CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-2.75%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.1B
AUM Growth
+$14.1B
(+2%)
Cap. Flow
-$359M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
32.88%
Holding
711
New
–
Increased
223
Reduced
317
Closed
43
Top Buys
| 1 |
XP
XP
|
$630M |
| 2 |
Amgen
AMGN
|
$44.8M |
| 3 |
NVIDIA
NVDA
|
$34.9M |
| 4 |
MINISO
MNSO
|
$32M |
| 5 |
Intuitive Surgical
ISRG
|
$31.7M |
Top Sells
| 1 |
Teck Resources
TECK
|
$474M |
| 2 |
Visa
V
|
$55.3M |
| 3 |
Johnson & Johnson
JNJ
|
$51.8M |
| 4 |
Microsoft
MSFT
|
$38.9M |
| 5 |
Danaher
DHR
|
$36.7M |
Sector Composition
| 1 | Healthcare | 26.08% |
| 2 | Technology | 25.64% |
| 3 | Financials | 11.81% |
| 4 | Industrials | 7.9% |
| 5 | Materials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
General Mills
GIS
$26.6B
| $18.9M | 0.13% |
295,651
+7,477
| +3% | +$478K |
|
152
Parker-Hannifin
PH
$94.8B
| $18.8M | 0.13% |
48,213
-24,913
| -34% | -$9.7M |
|
153
Xylem
XYL
$34B
| $18.2M | 0.13% |
201,013
+61,132
| +44% | +$5.54M |
|
154
3M
MMM
$81B
| $18.2M | 0.13% |
194,212
+157,289
| +426% | +$14.7M |
|
155
CVS Health
CVS
$93B
| $18.1M | 0.13% |
259,572
-47,200
| -15% | -$3.3M |
|
156
Datadog
DDOG
$46.2B
| $18.1M | 0.13% |
198,461
-2,664
| -1% | -$243K |
|
157
DuPont de Nemours
DD
$31.6B
| $17.9M | 0.13% |
240,234
+146,274
| +156% | +$10.9M |
|
158
Lamb Weston
LW
$7.88B
| $17.8M | 0.13% |
192,835
+30,690
| +19% | +$2.84M |
|
|
IMGN
159
DELISTED
Immunogen Inc
IMGN
| $17.8M | 0.13% |
1,122,588
+130,006
| +13% | +$2.06M |
|
160
Estee Lauder
EL
$33.1B
| $17.7M | 0.13% |
122,215
-77,298
| -39% | -$11.2M |
|
161
ITT
ITT
$13.1B
| $17.6M | 0.13% |
180,261
+89,264
| +98% | +$8.74M |
|
162
Sherwin-Williams
SHW
$90.5B
| $17.6M | 0.13% |
69,194
+51,659
| +295% | +$13.2M |
|
163
Caterpillar
CAT
$194B
| $17.6M | 0.13% |
64,605
-94,800
| -59% | -$25.9M |
|
164
Prologis
PLD
$103B
| $17.1M | 0.12% |
152,715
-406
| -0.3% | -$45.6K |
|
165
PNC Financial Services
PNC
$80.7B
| $16.7M | 0.12% |
136,865
+2,932
| +2% | +$358K |
|
166
Intuit
INTU
$187B
| $16.5M | 0.12% |
32,356
+1,260
| +4% | +$644K |
|
167
W.W. Grainger
GWW
$48.7B
| $16.5M | 0.12% |
23,807
-14,966
| -39% | -$10.4M |
|
168
Sarepta Therapeutics
SRPT
$1.98B
| $16.5M | 0.12% |
135,709
+35,709
| +36% | +$4.33M |
|
169
McKesson
MCK
$85.9B
| $16.1M | 0.11% |
37,091
+30,269
| +444% | +$13.2M |
|
170
MetLife
MET
$53.6B
| $16.1M | 0.11% |
256,014
+160,112
| +167% | +$10.1M |
|
171
Nuvalent
NUVL
$5.74B
| $16.1M | 0.11% |
350,017
+70,001
| +25% | +$3.22M |
|
172
Revolution Medicines
RVMD
$7.43B
| $15.6M | 0.11% |
561,948
-18,000
| -3% | -$498K |
|
173
Exelixis
EXEL
$9.95B
| $15.5M | 0.11% |
711,625
-290,012
| -29% | -$6.34M |
|
174
MongoDB
MDB
$25.5B
| $15.5M | 0.11% |
44,926
-14,760
| -25% | -$5.1M |
|
175
Legend Biotech
LEGN
$6.64B
| $15.5M | 0.11% |
231,032
| – | – |
|